Skip to main content
Family Medicine
ALL Specialities
ALL Specialities
/
Family Medicine
CME
COVID-19 Updates
The Journal of Family Practice
Current Issue
Past Issues
Author Guidelines
Specialties
Addiction Medicine
Cardiology
Dermatology
Diabetes
Endocrinology
Gastroenterology
Geriatrics
Hematology
Hepatology
Hospice & Palliative Medicine
Immunology
Infectious Diseases
Men's Health
Mental Health
Nephrology
Neurology
Oncology
Pain
Pediatrics
Pulmonology
Rheumatology
Sleep Medicine
Transgender Health
Women's Health
For Residents
Residents' Rapid Review
Multimedia
Audio
All Podcasts
Practice Alert Podcast
Video
3-in-3
Watch & Learn
Conference Coverage
AES: Development of unobtrusive seizure-detection devices continues
Publish date:
January 28, 2016
AT AES 2015
References
mzoler@frontlinemedcom.com
On Twitter
@mitchelzoler
Pages
« first
1
2
Recommended Reading
Glutamate-based neuroimaging identifies epileptic foci
MDedge Family Medicine
Pediatric pertussis tied to minor elevation in epilepsy risk
MDedge Family Medicine
AES: Neurologists ignore low driving risk from epilepsy-drug withdrawal
MDedge Family Medicine
AES: Hormonal contraceptives can boost seizures in epileptics
MDedge Family Medicine
AES: Cannabidiol shows promising epilepsy safety and efficacy
MDedge Family Medicine
AES: Many U.S. epilepsy patients receive suboptimal treatment
MDedge Family Medicine
AES: Three studies show generic lamotrigine equals Lamictal
MDedge Family Medicine
Good luck convincing patients that generics equal brand-name drugs
MDedge Family Medicine
AES: Sparse evidence hints at epilepsy disease modification
MDedge Family Medicine
AES: Seizure freedom attainable for most epilepsy patients
MDedge Family Medicine
Pediatrics
Neurology
All Specialties
